Immupharma (IMM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

6.66p
   
  • Change Today:
    -0.34p
  • 52 Week High: 17.60
  • 52 Week Low: 1.50
  • Currency: UK Pounds
  • Shares Issued: 502.72m
  • Volume: 835,990
  • Market Cap: £33.48m
  • RiskGrade: 328
  • Beta: 0.93

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Timothy Paul McCarthy 1,488,462 £99,132
Lisa Baderoon 583,963 £38,892
Tim Franklin 525,000 £34,965

Major Shareholders

Notifier** Holding Value*
Lanstead Capital LP 25,108,044 £1,672,196
Invesco Ltd 17,872,341 £1,190,298
Aviva Investors Global 11,285,180 £751,593
Alora Pharmaceuticals LLC 10,909,091 £726,546
M&G Investments 7,600,000 £506,160
Prudential plc 7,600,000 £506,160
Capital Income Builder 4,870,367 £324,366
Dr R Zimmer 4,551,553 £303,133
Odey Asset Management 3,433,319 £228,659
Rhone Trustees (Switzerland) SA 3,386,000 £225,508
Pictet Overseas Trust Corporation Limited 3,287,500 £218,948

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 6.66p
Change Today -0.34p
% Change -4.86 %
52 Week High 17.60
52 Week Low 1.50
Volume 835,990
Shares Issued 502.72m
Market Cap £33.48m
Beta 0.93
RiskGrade 328

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average29.39% below the market average
21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average21.95% above the sector average
Price Trend
67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average67.97% below the market average
40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average40.91% below the sector average
Income Not Available
Growth Not Available

Immupharma Dividends

No dividends found

Trades for 23-Jan-2026

Time Volume / Share Price
16:29 65 @ 6.54p
16:29 74 @ 6.80p
16:29 88 @ 6.80p
16:17 441 @ 6.80p
16:16 1,500 @ 6.80p

Immupharma Key Personnel

CEO Timothy Paul McCarthy

Top of Page